196 related articles for article (PubMed ID: 37113060)
1. Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients.
Ferrari F; Rossi D; Ricciardi A; Morasso C; Brambilla L; Albasini S; Vanna R; Fassio C; Begenisic T; Loi M; Bossi D; Zaliani A; Alberici E; Lisi C; Morotti A; Cavallini A; Mazzacane F; Nardone A; Corsi F; Truffi M
J Cereb Blood Flow Metab; 2023 Sep; 43(9):1601-1611. PubMed ID: 37113060
[TBL] [Abstract][Full Text] [Related]
2. Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke.
Barba L; Vollmuth C; Abu-Rumeileh S; Halbgebauer S; Oeckl P; Steinacker P; Kollikowski AM; Schultz C; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Neugebauer H; Otto M
Sci Rep; 2023 Nov; 13(1):20941. PubMed ID: 38017278
[TBL] [Abstract][Full Text] [Related]
3. Incremental value of serum neurofilament light chain and glial fibrillary acidic protein as blood-based biomarkers for predicting functional outcome in severe acute ischemic stroke.
Vollmuth C; Fiessler C; Montellano FA; Kollikowski AM; Essig F; Oeckl P; Barba L; Steinacker P; Schulz C; Ungethüm K; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Otto M; Neugebauer H
Eur Stroke J; 2024 Feb; ():23969873241234436. PubMed ID: 38400734
[TBL] [Abstract][Full Text] [Related]
4. Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's disease.
Mao S; Teng X; Li Z; Zu J; Zhang T; Xu C; Cui G
Brain Res; 2023 Apr; 1805():148271. PubMed ID: 36754139
[TBL] [Abstract][Full Text] [Related]
5. Neurofilament Light Chain and Glial Fibrillary Acidic Protein as early prognostic biomarkers after out-of-hospital cardiac arrest.
Klitholm M; Jeppesen AN; Christensen S; Parkner T; Tybirk L; Kirkegaard H; Sandfeld-Paulsen B; Grejs AM
Resuscitation; 2023 Dec; 193():109983. PubMed ID: 37778613
[TBL] [Abstract][Full Text] [Related]
6. The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease.
Teng X; Mao S; Wu H; Shao Q; Zu J; Zhang W; Zhou S; Zhang T; Zhu J; Cui G; Xu C
J Neurochem; 2023 Apr; 165(2):268-276. PubMed ID: 36776136
[TBL] [Abstract][Full Text] [Related]
7. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.
Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM
Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401
[TBL] [Abstract][Full Text] [Related]
8. Serum glial fibrillary acidic protein and neurofilament light chain in treatment-naïve patients with unipolar depression.
Hviid CVB; Benros ME; Krogh J; Nordentoft M; Christensen SH
J Affect Disord; 2023 Oct; 338():341-348. PubMed ID: 37336248
[TBL] [Abstract][Full Text] [Related]
9. Early plasma biomarker dynamic profiles are associated with acute ischemic stroke outcomes.
Correia M; Silva I; Gabriel D; Simrén J; Carneiro A; Ribeiro S; Dória HM; Varela R; Aires A; Minta K; Antunes R; Felgueiras R; Castro P; Blenow K; Magalhães R; Zetterberg H; Maia LF
Eur J Neurol; 2022 Jun; 29(6):1630-1642. PubMed ID: 35124870
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal follow-up of serum biomarkers in patients with neuromyelitis optica spectrum disorder.
Kim H; Lee EJ; Kim S; Choi LK; Kim HJ; Kim HW; Chung K; Seo D; Moon S; Kim KK; Lim YM
Mult Scler; 2022 Apr; 28(4):512-521. PubMed ID: 34212756
[TBL] [Abstract][Full Text] [Related]
11. Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis.
Pauwels A; Van Schependom J; Devolder L; Van Remoortel A; Nagels G; Bjerke M; D'hooghe MB
Mult Scler; 2022 Oct; 28(11):1685-1696. PubMed ID: 36059263
[TBL] [Abstract][Full Text] [Related]
12. Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures.
Akel S; Asztely F; Banote RK; Axelsson M; Zetterberg H; Zelano J
Epilepsia; 2023 Oct; 64(10):2690-2700. PubMed ID: 37469165
[TBL] [Abstract][Full Text] [Related]
13. Serum neurofilament-light and glial fibrillary acidic protein levels in hydroxychloroquine-treated primary progressive multiple sclerosis.
Camara-Lemarroy C; Silva C; Gohill J; Yong VW; Koch M
Eur J Neurol; 2023 Jan; 30(1):187-194. PubMed ID: 36214614
[TBL] [Abstract][Full Text] [Related]
14. Relationship between increased serum neurofilament light chain and glial fibrillary acidic protein levels with non-motor symptoms in patients with Parkinson's disease.
Yin P; Niu X; Guan C; Zhang Z; Liu Y; Li J; Cui G; Zan K; Xu C
Psychogeriatrics; 2024 Mar; 24(2):415-425. PubMed ID: 38339819
[TBL] [Abstract][Full Text] [Related]
15. Plasma neurofilament light chain level predicts outcomes in stroke patients receiving endovascular thrombectomy.
Chen CH; Chu HJ; Hwang YT; Lin YH; Lee CW; Tang SC; Jeng JS
J Neuroinflammation; 2021 Sep; 18(1):195. PubMed ID: 34511123
[TBL] [Abstract][Full Text] [Related]
16. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
[TBL] [Abstract][Full Text] [Related]
17. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients.
Veje M; Griška V; Pakalnienė J; Mickienė A; Bremell D; Zetterberg H; Blennow K; Lindquist L; Studahl M
Eur J Neurol; 2023 Oct; 30(10):3182-3189. PubMed ID: 37431060
[TBL] [Abstract][Full Text] [Related]
18. NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis.
Ammitzbøll C; Dyrby TB; Börnsen L; Schreiber K; Ratzer R; Romme Christensen J; Iversen P; Magyari M; Lundell H; Jensen PEH; Sørensen PS; Siebner HR; Sellebjerg F
Mult Scler Relat Disord; 2023 Sep; 77():104854. PubMed ID: 37418931
[TBL] [Abstract][Full Text] [Related]
19. Utility of serum neurofilament light chain and glial fibrillary acidic protein as diagnostic biomarkers of freezing of gait in Parkinson's disease.
Liu X; Liu X; Liu Y; Yang B; Li Y; Li F; Qian K; Zu J; Zhang W; Zhou S; Zhang T; Liu J; Cui G; Xu C
Brain Res; 2024 Jan; 1822():148660. PubMed ID: 37924925
[TBL] [Abstract][Full Text] [Related]
20. Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases.
Lin X; Lu T; Deng H; Liu C; Yang Y; Chen T; Qin Y; Xie X; Xie Z; Liu M; Ouyang M; Li S; Song Y; Zhong N; Qiu W; Zhou C
J Neurol; 2022 Feb; 269(2):815-823. PubMed ID: 34283286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
